Additional information
| Active substance | Losartan |
|---|---|
| Chemical name | 2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-methanol |
| Side effects | Dizziness, light-headedness, nasal congestion, back pain, and fatigue |
| Effects | Lowers blood pressure, reduces the risk of stroke in patients with high blood pressure and left ventricular hypertrophy |
| Dosage (sports) | Not applicable as it is not used for performance enhancement |
| Dosage (medical) | Typically starts at 50 mg once daily, can increase to 100 mg once daily depending on the patient's response and condition |
| Half-life | 1.5 to 2 hours, but the active metabolite has a half-life of 6 to 9 hours |
| Main action | Lowers blood pressure by blocking the receptors that angiotensin II acts on |
| Substance class | Angiotensin II receptor blocker (ARB) |
| Formula | C22H23ClN6O |
| Storage conditions | Store at room temperature away from moisture and heat |
| Trade name | Cozaar |
| Blood pressure | Effectively reduces high blood pressure |
| Also known as | Losartan Potassium |
| Strength | 25mg |
| Lab Test | Blood pressure monitoring, renal function tests |
| Hepatotoxicity | Rare |
| Water Retention | Minimal to none |
| Use in sports | None, as it does not enhance athletic performance |
| Manufacturer | Intas Pharmaceuticals Ltd. |
| Packing | 10 tabs/blister |
Reviews
There are no reviews yet.